Clinical trial
Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial…
NCT00237614 · University of Milan, Other · Completed
Key facts
| NCT number | NCT00237614 |
|---|---|
| Title | Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction |
| Lead sponsor | University of Milan, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Contrast-Induced Nephropathy, Acute Myocardial Infarction |
| Intervention type | Drug |
| Interventions | intravenous and oral N-acetylcysteine |
| Enrollment | 300 |
| Start date | Feb 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Oct 12, 2005 |
| Last update posted | Jul 18, 2006 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: